Product
Nebivolol
Name
Nebivolol
INN Name
Nebivolol
FDA Approved
Yes
10 clinical trials
1 organization
22 indications
1 document
Indication
open-angle glaucomaIndication
ocular hypertensionIndication
Healthy SubjectsIndication
HypertensionIndication
Myocardial BridgingIndication
Intracranial AneurysmIndication
Cardiovascular DiseasesIndication
Myocardial InfarctionIndication
Non-ST Elevation Myocardial InfarctionIndication
ST Elevation Myocardial InfarctionIndication
Breast CancerIndication
lymphomaIndication
Large B-CellIndication
DiffuseIndication
CardiotoxicityIndication
Left Ventricular DysfunctionIndication
Chemotherapy EffectIndication
AnginaIndication
Microvascular anginaIndication
Vasospastic anginaIndication
Myocardial Bridge of Coronary ArteryClinical trial
Randomized, Multicenter, Observer-Masked Study to Compare Safety/Efficacy of Nebivolol Suspension 0.5% or 1.0%, or Timolol Suspension 0.5% to Timolol Solution 0.5% in Participants With Primary Open Angle Glaucoma or Ocular HypertensionStatus: Completed, Estimated PCD: 2022-03-31
Clinical trial
A Bioequivalence Study of Nebivolol Tablets 5 mg Relative to Nebilet Tablets 5 mg in Healthy Thai Volunteers Under Fasting ConditionStatus: Not yet recruiting, Estimated PCD: 2024-08-17
Clinical trial
Open-label, Multicenter, multinAtionaL, inteRventional Clinical Trial to Assess Efficacy and Safety of the exteMporaneous combInation of Nebivolol and Ramipril in hypertenSIve pAtients - ARTEMISIA StudyStatus: Recruiting, Estimated PCD: 2024-05-03
Clinical trial
Open-laBel, Multicenter, multinatiOnal, inTerventional Clinical Trial to Assess effIcacy and Safety of the Extemporaneous Combination of nEbivoLol and amLodipine in Grade 1-2 Hypertensive patIents Versus Each MonotherapyStatus: Completed, Estimated PCD: 2022-11-15
Clinical trial
Efficacy of Medical Therapy in Women and Men With Angina and Myocardial BridgingStatus: , Estimated PCD: 2025-01-15
Clinical trial
Beta-blockade in Unruptured Intracranial AneurysmStatus: Not yet recruiting, Estimated PCD: 2029-01-01
Clinical trial
Use of Determination of Drug Levels to Optimize Pharmacotherapy of Heart FailureStatus: Not yet recruiting, Estimated PCD: 2026-04-01
Clinical trial
Danish Trial of Beta Blocker Treatment After Myocardial Infarction Without Reduced Ejection Fraction (DANBLOCK)Status: Recruiting, Estimated PCD: 2024-12-10
Clinical trial
Cardioprotective Effects of Nebivolol Versus Placebo in Patients Undergoing Chemotherapy With Anthracyclines (CONTROL Trial)Status: Active (not recruiting), Estimated PCD: 2023-02-28
Clinical trial
A Randomized Controlled Study of Targeted Medical Therapy Versus Placebo for Angina and Non- Obstructive Coronary Arteries: The MVP-ANOCA StudyStatus: Not yet recruiting, Estimated PCD: 2026-12-01
Document
DailyMed Label: NebivololOrganization
A-S Medication Solutions